ascendis pharma glp-1 receptor agonist medications Ozempic maker Novo Nordisk is working on a once-monthly weight-loss drug Endocrinology Newsmakers: Drugmakers work on

Mechanisms of Action and Cellular Pathways MDPI - Stable Gastric Pentadecapeptide BPC 157 Pleiotropic Beneficial Activity: Highlights cytoprotection, neurotransmitter interactions, and VEGF activation

And hey, those things can pop up way earlier than expected, thanks to a bunch of reasons some inside our bodies, others from the world outside

The medicine has given me energy and curbed my appetite

However, that was not the case

PMID: 34456789 Williams, J., et al

It stimulates the synthesis of key extracellular matrix components while neutralizing reactive oxygen species, restoring firmness and reducing oxidative damage that accelerates visible and molecular aging